Back to search

Article

A <i>Drosophila in vivo</i> chemical screen reveals that combination drug treatment targeting MEK and DGKα mitigates Ras-driven polarity-impaired tumourigenesis

2022-03-16

Abstract excerpt

The RAS oncogene and upregulation of the RAS signalling pathway is highly prevalent in human cancer, and therefore, therapeutically targeting the RAS pathway is a common treatment in cancer. However, RAS pathway upregulation is not sufficient to drive malignant cancer, since senescence mechanisms prevent cancer progression. Thus, additional mutations, such as mutations that prevent senescence or alter the tissue...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
844efb24-9df8-5465-9ed6-9473838ce772
DOI
10.1101/2022.03.14.484232
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A <i>Drosophila in vivo</i> chemical screen reveals that combination drug treatment targeting MEK and DGKα mitigates Ras-driven polarity-impaired tumourigenesisDOI 10.1101/2022.03.14.484232
Select a neighboring publication to make it the new centre.